Interleukin (IL)-13 is the predominant Th2 cytokine in localized cutaneous leishmaniasis lesions and renders specific CD4+ T cells unresponsive to IL-12

Journal of Infectious Diseases

Volumn 183, Issue 6, 2001, Pages 953-959

  Bourreau, Eliane ^a   Prévot, Ghislaine ^a   Pradinaud, Roger ^a   Launois, Pascal ^a  

^a CENTRE HOSPITALIER DE CAYENNE   (French Guiana)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 4;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEISHMANIA; LEISHMANIASIS; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH2 CELL;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN-12; INTERLEUKIN-13; INTERLEUKIN-4; LEISHMANIA GUYANENSIS; LEISHMANIASIS, CUTANEOUS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-12; TH2 CELLS; TRANS-ACTIVATION (GENETICS);

EID: 0035869169     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/319249     Document Type: Article

References (34)

1. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties
2. Functional diversity of helper T lymphocytes
3. The regulatinn of immunity to Leishmania major
4. + T cells resulting in a state of unresponsiveness to 1L-12
5. Selective expression of an interleukin-12 receptor component by human T helper 1 cells
6. Antibodies to the IL-12 receptor β2 chain mark human Th1 but not Th2 cells in vitro and in vivo
7. Expression of the IL-12 receptor β1 and β2 subunits in human tuberculosis
8. Regulation of the interleukin (IL)-12Rβ2 subunit expression in developing T helper (Th1) and Th2 cells
9. Interleukin-13 induces interleukin-4-independent IgG4 and IgE synthesis and CD23 expression by human B cells
10. Immunologic determinants of disease evolution in localized cutaneous leishmanisis due to Leishmania major
11. Cytokine patterns in the pathogenesis of human leishmaniasis
12. The cutaneous lesion in American leishmaniasis: Leukocyte subsets, cellular interaction and cytokine production
13. Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction
14. Susceptibility to Leishmania major infection in IL-4-deficient mice
15. IL-4 and IL-4 receptor deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains
16. IL-13 is a susceptibility factor for Leishmania major infection
17. Requirement of IL-13 independently of IL-4 in experimental asthma
18. Interleukin-13: Central mediator of allergic asthma
19. Interleukin-4 and interleukin-13: Their similarities and discrepancies
20. + T cells which are NK1.1
21. Gene expression analysis using quantitative reverse transcription-polymerase chain reaction and a multispecific internal control
22. Recognition of protozoan parasite antigens by murine T lymphocytes
23. A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits
24. + T cells in BALB/c mice infected with Leishmania major instructs Th2 cell development and susceptibility to infection
25. Early production of IL-4 in susceptible mice infected with Leishmania major rapidly induces IL-12 unresponsiveness
26. Differential regulation of the interleukin-12 receptor during the innate immune response to Leishmania major
27. T-cell and cytokine responses in leishmaniasis
28. Cytokine patterns in the pathogenesis of human leishmaniasis
29. Effects of IL-13 on phenotype cytokine production and cytotoxic function of human macrophages
30. Th1 and Th2 in human diseases
31. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses
32. Potential anti-inflammatory effects of interleukin-4: Suppression of human monocyte tumor necrosis factor alpha, interleukin 1 and prostaglandin E2
33. Interleukin-13 inhibits inducible nitric oxide synthase expression in human mesangial cells
34. A novel 4-kb interleukin-13 receptor alpha mRNA expressed in human B, T and endothelial cells encoding an alternate type II interleukin-4/interleukin-13 receptor